Publications by authors named "Susan Blaney"

Claim this Profile
P
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Frank Y Lin, Austin Stuckert, Candise Tat, Mark White, Lucia Ruggieri, Susan Blaney

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report.
Jack M Su, Lindsay B Kilburn, David B Mansur, Mark Krailo, Allen Buxton, Susan M Blaney

Neuro Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas.
Kala Y Kamdar, Taylor O Kim, Erin E Doherty, Thomas M Pfeiffer, Shawki L Qasim, Susan M Blaney

Pediatr Hematol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.
Amir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, Hsiao-Chi Chen, Selin Jessa, Susan M Blaney

Cancer Discov· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).
Jennifer H Foster, Stephan D Voss, David C Hall, Charles G Minard, Frank M Balis, Susan M Blaney

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212).
Emily Greengard, Yael P Mosse, Xiaowei Liu, Charles G Minard, Joel M Reid, Susan M Blaney

Cancer Chemother Pharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.
Patricia A Baxter, Jack M Su, Arzu Onar-Thomas, Catherine A Billups, Xiao-Nan Li, Susan M Blaney

Neuro Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
Jack Meng-Fen Su, Jeffrey C Murray, Rene Y McNall-Knapp, Daniel C Bowers, Shafqat Shah, Susan M Blaney

Pediatr Blood Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
Eric S Schafer, Rachel E Rau, Stacey L Berg, Xiaowei Liu, Charles G Minard, Susan M Blaney

Pediatr Blood Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921).
Yael P Mossé, Elizabeth Fox, David T Teachey, Joel M Reid, Stephanie L Safgren, Susan M Blaney

Clin Cancer Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Recent advances in pediatric oncology.
Susan M Blaney

Curr Opin Pediatr· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Activities of the Coalition of Cancer Cooperative Groups.
Monica M Bertagnolli, Susan M Blaney, Charles D Blanke, Walter J Curran, Janet Dancey

J Natl Cancer Inst· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.
Peter D Cole, Kathleen M McCarten, Qinglin Pei, Menachem Spira, Monika L Metzger, Susan M Blaney

Lancet Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
Meredith K Chuk, Brigitte C Widemann, Charles G Minard, Xiaowei Liu, AeRang Kim, Susan Blaney

Pediatr Blood Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).
Eric S Schafer, Rachel E Rau, Stacey Berg, Xiaowei Liu, Charles G Minard, Susan M Blaney

Pediatr Blood Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
Rachel E Rau, ZoAnn Dreyer, Mi Rim Choi, Wei Liang, Roman Skowronski, Susan M Blaney

Pediatr Blood Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
Lindsay B Kilburn, Mehmet Kocak, Patricia Baxter, Tina Young Poussaint, Arnold C Paulino, Susan M Blaney

Pediatr Blood Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in pediatric oncology.
Susan M Blaney

Curr Opin Pediatr· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).
James I Geller, John P Perentesis, Xiaowei Liu, Charles G Minard, Rachel A Kudgus, Susan M Blaney

Pediatr Blood Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report.
Sarah E S Leary, Julie R Park, Joel M Reid, Andrew T Ralya, Sylvain Baruchel, Susan Blaney

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
Yael P Mossé, Stephan D Voss, Megan S Lim, Delphine Rolland, Charles G Minard, Susan M Blaney

J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114).
Susan R Rheingold, Sarah K Tasian, James A Whitlock, David T Teachey, Michael J Borowitz, Susan M Blaney

Br J Haematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
50 Years Ago in The Journal of Pediatrics: Diencephalic Syndromes of Infancy: Report of 3 Children with Emaciation Syndrome and Disproportionately Large Hands and Feet.
Emily B Heikamp, Susan M Blaney

J Pediatr· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium.
Frank M Balis, Patrick A Thompson, Yael P Mosse, Susan M Blaney, Charles G Minard

Cancer Chemother Pharmacol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.
Joanne P Lagmay, Mark D Krailo, Ha Dang, AeRang Kim, Douglas S Hawkins, Susan M Blaney

J Clin Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis